Multiple sclerosis is a chronic, inflammatory medical condition, which results in demyelination, axonal transection, and neurodegeneration of the nerve cells of the brain and spinal cord. The immune system of the body targets the neurons within the CNS and damages the myelin sheath. It is a potentially debilitating disease, causing disruption in the communication and coordination functions of the body. The symptoms of multiple sclerosis differ widely, subject to the extent of damage and the number of neurons affected. Some of the symptoms observed are fatigue, numbness, spasticity, bladder dysfunction, cognitive changes, emotional changes, and depression. An individual with severe form of the disease can experience speech and movement problems.
Scope of the Report:
This report studies the Multiple Sclerosis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, ...
Table of Contents
1 Multiple Sclerosis Market Overview
1.1 Product Overview and Scope of Multiple Sclerosis
1.2 Classification of Multiple Sclerosis by Types
1.2.1 Global Multiple Sclerosis Revenue Comparison by Types (2017-2023)
1.2.2 Global Multiple Sclerosis Revenue Market Share by Types in 2017
1.2.3 Injectable agents
1.2.4 Oral agents
1.3 Global Multiple Sclerosis Market by Application
1.3.1 Global Multiple Sclerosis Market Size and Market Share Comparison by Applications (2013-2023)
1.4 Global Multiple Sclerosis Market by Regions
1.4.1 Global Multiple Sclerosis Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Multiple Sclerosis Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Multiple Sclerosis Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japa ...